Restalyst received Singapore HSA Provisional Authorization approval for COVID19N-REAAD™ Anti-SARS-CoV-2 Nucleocapsid Protein IgG ELISA.

August 07, 2020 Restalyst

This is a product intended for qualitative detection of IgG antibodies to SARS-CoV-2 Nucleocapsid Protein in human serum and plasma.